CaviTAU – THE ADVANTAGES IN THE PALM OF YOUR HANDS!

The newly developed CaviTAU® also provides diagnostic information about bone density and quality in the jawbone area.

In terms of clinical research on factors that contribute to disease, it can play an important role among the different forms of systemic diseases.

The CaviTAU device is a valuable clinical tool that provides information that does not just come down to an isolated diagnosis but concerns the general health of your patients.

(see also Lechner J, von Baehr V. RANTES and fibroblast growth factor 2 in jawbone cavitations: triggers for systemic disease? Int. Jour. of General Medicine; 2013:6. http://www.dovepress.com/articles.php?article_id=12842 )

WHAT AND HOW ARE MEASUREMENTS MADE WITH CAVITAU?

CaviTAU® is an imaging process to measure bone density and quality in the jawbone area.

SHOW MORE

The CaviTAU® device for Trans-Alveolar Ultrasound (TAU) developed by Dr Lechner involves a transmission ultrasound procedure.

In doing so, imaging and contrast are gained from the differences of attenuation and/or the different durations of the ultrasonic waves while transmitting through the entire medium 1)
The speed of sound propagation in cancellous bones has a clear linear correlation with bone density 2)

 

Speed is a good indicator of bone density in order to detect damages caused by factors such as thinning of the trabecular networks. Quantitative ultrasonic measurement has become a clinical standard in the case of primary osteoporosis in bones with complete loss of the trabecular structure.

The evaluation is based on colour fields, which immediately make the softened osseous areas in the jaw plausible for the patients.

The image documents created in this manner contribute to an improved explanation and informed consent of the patient compared to the X-ray images that ordinary people find difficult to understand.

 

1) [ Laugier P: The basic physics of ultrasound. In: Njeh C, Hans D, Fuerst C,Gluer C, Genant HK, eds. Quantitative ultrasound: assessment of osteoporosis and bone status. United Kingdom: Martin Dunitz Ltd., 1999:48-59.].

2) [Serpe L, Rho JY: The nonlinear transition period of broadband ultrasound attenuation as bone density varies. JBiomech 1996; 29:963-966./ Nicholson PHF, Njeh CF: Ultrasonic studies of cancellous bone in vitro. In:Njeh C, Hans D, Fuerst C, Gluer C, Genant HK, eds. Quantitative ultra-sound: assessment of osteoporosis and bone status. United Kingdom Martin Dunitz Ltd.., 1999:204-206.].

SAFE AND EFFECTIVE METHOD

All radiological processes are linked to health risks posed by radiation exposure. Ultrasound applications with CaviTAU® are completely harmless…

SHOW MORE

Bis Januar 2010 wurden über 540.000 Patienten mit TAU-Verfahren ohne Strahlenbelastung untersucht.

CaviTAU® is not a device that is used to diagnose diseases. Nevertheless, thousands of cases supported by TAU images helped examining doctors make decisions on bone density and on whether they are dealing with healthy bone or not.

LITTLE SPACE

The CaviTAU device only requires a small amount of space and can be installed in any dental practice to supplement the existing X-ray machines.

NON-INVASIVE AND COST-EFFICIENT

In terms of the legally prescribed duty of care, CaviTAU® can be used as a non-invasive and cost-effective adjuvant for medical indication in the event of the following procedures:

  1. suspicion of jawbone necrosis with chronic facial pain
  2. suspicion of jawbone necrosis with immunological and tumour diseases
  3. To protect the resilient bone during implantations to ensure the success of dental implants.

CURRENT STATE OF DEVELOPMENT

We would like to inform you of the current state of development of the new CaviTAU device. In the following, you will experience the development of the device very closely in the individual contributions...